Multidrug resistance from the clinical point of view

This publication has 37 references indexed in Scilit:

• Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine
  European Journal of Cancer and Clinical Oncology, 1991
• The role of topoisomerase II in drug resistance
  Life Sciences, 1991
• Phase I and Pharmacokinetic Trial of Intraperitoneal Etoposide in Combination With the Multidrug-Resistance-Modulating Agent Dipyridamole
  JNCI Journal of the National Cancer Institute, 1991
• Systemic Toxic Effects Associated With High-Dose Verapamil Infusion and Chemotherapy Administration
  JNCI Journal of the National Cancer Institute, 1991
• HT1080/DR4: A P-Glycoprotein-Negative Human Fibrosarcoma Cell Line Exhibiting Resistance to Topoisomerase II-Reactive Drugs Despite the Presence of a Drug-Sensitive Topoisomerase II
  JNCI Journal of the National Cancer Institute, 1990
• Expression of mdr1 and mdr3 Multidrug-resistance Genes in Human Acute and Chronic Leukemias and Association With Stimulation of Drug Accumulation by Cyclosporine
  JNCI Journal of the National Cancer Institute, 1990
• Expression of themdr3 gene in prolymphocytic leukemia: Association with cyclosporin-a-induced increase in drug accumulation
  International Journal of Cancer, 1990
• Overexpression of the MDRL gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin‐A
  International Journal of Cancer, 1990
• Nonproductive Rearrangement of DNA Topoisomerase I and II Genes: Correlation With Resistance to Topoisomerase Inhibitors
  JNCI Journal of the National Cancer Institute, 1989
• Sequence of mdr3 cDNA encoding a human P-glycoprotein
  Gene, 1988